Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126814291 | 12681429 | 1 | I | 20160506 | 20160810 | 20160824 | 20160824 | EXP | FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-066394 | BRISTOL MYERS SQUIBB | 72.68 | YR | M | Y | 0.00000 | 20160824 | CN | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126814291 | 12681429 | 1 | PS | COUMADINE | WARFARIN SODIUM | 1 | Oral | UNK, QD | Y | 9218 | TABLET | QD | |||||||
| 126814291 | 12681429 | 2 | SS | RAMIPRIL. | RAMIPRIL | 1 | Oral | UNK, QD | Y | 0 | QD | ||||||||
| 126814291 | 12681429 | 3 | SS | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 1 DF, UNK | Y | 0 | 1 | DF | |||||||
| 126814291 | 12681429 | 4 | SS | NEBIVOLOL. | NEBIVOLOL | 1 | Oral | 0.5 DF, BID | Y | 0 | .5 | DF | BID | ||||||
| 126814291 | 12681429 | 5 | SS | KALEORID | POTASSIUM CHLORIDE | 1 | Oral | UNK, BID | Y | 0 | BID | ||||||||
| 126814291 | 12681429 | 6 | SS | AMIODARONE | AMIODARONE | 1 | Oral | UNK, QD | Y | 0 | QD | ||||||||
| 126814291 | 12681429 | 7 | SS | SPIRONOLACTONE. | SPIRONOLACTONE | 1 | Oral | UNK, QD | Y | 0 | QD | ||||||||
| 126814291 | 12681429 | 8 | SS | HEMIGOXINE NATIVELLE | DIGOXIN | 1 | Oral | UNK, QD | Y | 0 | TABLET | QD | |||||||
| 126814291 | 12681429 | 9 | C | VITAMIN B1 AND B6 | PYRIDOXINE HYDROCHLORIDETHIAMINE HYDROCHLORIDE | 1 | Unknown | UNK, TID | U | 0 | TID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126814291 | 12681429 | 1 | Product used for unknown indication |
| 126814291 | 12681429 | 2 | Product used for unknown indication |
| 126814291 | 12681429 | 3 | Product used for unknown indication |
| 126814291 | 12681429 | 4 | Product used for unknown indication |
| 126814291 | 12681429 | 5 | Product used for unknown indication |
| 126814291 | 12681429 | 6 | Product used for unknown indication |
| 126814291 | 12681429 | 7 | Product used for unknown indication |
| 126814291 | 12681429 | 8 | Product used for unknown indication |
| 126814291 | 12681429 | 9 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126814291 | 12681429 | HO |
| 126814291 | 12681429 | OT |
| 126814291 | 12681429 | LT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126814291 | 12681429 | Acidosis | |
| 126814291 | 12681429 | Acute kidney injury | |
| 126814291 | 12681429 | Dehydration | |
| 126814291 | 12681429 | Dialysis | |
| 126814291 | 12681429 | Hyperkalaemia | |
| 126814291 | 12681429 | Hyponatraemia | |
| 126814291 | 12681429 | Hypovolaemic shock | |
| 126814291 | 12681429 | Overdose |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126814291 | 12681429 | 1 | 20160506 | 0 | ||
| 126814291 | 12681429 | 2 | 20160506 | 0 | ||
| 126814291 | 12681429 | 3 | 20160506 | 0 | ||
| 126814291 | 12681429 | 4 | 20160506 | 0 | ||
| 126814291 | 12681429 | 5 | 20160506 | 0 | ||
| 126814291 | 12681429 | 6 | 20160506 | 0 | ||
| 126814291 | 12681429 | 7 | 20160506 | 0 |